Kybora
KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

October 8, 2025
News
Strategic collaboration combines KYBORA’s global biopharma network with ACA Pharma’s 30–90 day Macau registration model to expedite access for rare disease and pediatric therapies in China.  KYBORA and ACA Pharma…
READ MORE
KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

October 8, 2025
News
Strategic collaboration combines KYBORA’s global biopharma network with ACA Pharma’s 30–90 day Macau registration model to expedite access for rare…
READ MORE

Podcast: Healthcare Insights by KYBORA

September 23, 2025
News
Episode 7: CEO Insights: Immunotherapy Innovations, AI Challenges and Clinical Trial Observations In our new episode CEO Insights: Immunotherapy Innovations, AI…
READ MORE

Managing Director – Biopharma Investment Banking (Broker-Dealer Head)

September 18, 2025
News
KYBORA Capital is a life sciences focused investment bank that combines deep domain expertise with agile execution, offering a Managing…
READ MORE

KYBORA at BioArbor Life Science Forum

September 16, 2025
News
Shaping the Future of Life Sciences.  KYBORA’s Founder and CEO, Alan Vanderborght, participated in BioArbor Life Science Forum in a…
READ MORE
The AI Effect on the Biopharma Market

Podcast: Healthcare Insights by KYBORA

September 11, 2025
News
Episode 6: The AI Effect on the Biopharma Market In our latest episode, The AI Effect on the Biopharma Market,…
READ MORE
Global Medicine Market Outlook 2024–2029

Global Medicine Market Outlook 2024–2029: Strategic insights for C-Level Leaders

August 28, 2025
News
According to IQVIA Institute’s report “The Global Use of Medicines Outlook through 2029”, the global pharmaceutical landscape is entering a…
READ MORE

Podcast: Healthcare Insights by KYBORA

July 30, 2025
News
Episode 5: Global Biopharma Today: Funding Trends and Future Outlook In our latest episode, KYBORA's CEO, Alan Vanderborght, sits down…
READ MORE
Bago & Polaris

KYBORA served as Exclusive Advisor to Bioprofarma Bagó on Strategic In-Licensing Agreement with Polaris

July 29, 2025
News
KYBORA, a leading global advisory firm specializing in biopharma transactions, is proud to announce its role as exclusive advisor to…
READ MORE
A new milestone in Biosimilars

KYBORA proudly announces a new milestone in Biosimilars

July 15, 2025
News
KYBORA acted as the exclusive advisor to Xbrane Biopharma (Nasdaq Stockholm: XBRANE) on its strategic agreement with Alvotech for the…
READ MORE
KYBORA at BIO International

KYBORA at BIO International 2025

July 10, 2025
News
Basel Area Business & Innovation Hosts Beyond Venture Capital Panel At this year’s BIO International Convention, the Basel Area Business…
READ MORE
MarketingInternIEFP

Marketing Intern (IEFP Internship)

July 8, 2025
Uncategorized
We’re looking for a highly motivated Marketing Intern to join our Marketing team.In this role, you’ll collaborate closely with our…
READ MORE
FoundationRwanda

KYBORA and Foundation Rwanda host a Benefit Dinner to Empower Second-Generation Genocide Survivors

July 1, 2025
News
KYBORA, a global healthcare advisory firm and investment bank, and Foundation Rwanda, a nonprofit organization committed to supporting survivors of…
READ MORE

TYPE & ENTER: